3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
37
Lung Neoplasms
21
Brain Neoplasms
21
Prostatic Neoplasms
20
Pancreatic Neoplasms
20
Neoplasm Metastasis
20
Carcinoma, Hepatocellular
17
Melanoma
15
Breast Neoplasms
12
Squamous Cell Carcinoma of Head and Neck
8
Carcinoma, Renal Cell
8
Neoplasms
7
Small Cell Lung Carcinoma
6
Liver Neoplasms
6
Glioblastoma
6
Sarcoma
5
Head and Neck Neoplasms
4
Salivary Gland Neoplasms
3
Recurrence
3
Kidney Neoplasms
3
Gliosarcoma
3
Glioma
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Cholangiocarcinoma
3
Adenocarcinoma of Lung
3
Uveal Melanoma
2
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Sarcoma, Ewing
2
Interventions
Everolimus
16
Octreotide
6
pembrolizumab
5
lanreotide
5
Sunitinib
5
Magnetic Resonance Spectroscopy
5
gallium Ga 68 dotatate
4
cabozantinib
4
Nivolumab
4
Carboplatin
4
telotristat ethyl
3
lenvatinib
3
arginyllysine
3
Specimen Handling
3
Etoposide
3
Erlotinib Hydrochloride
3
Bevacizumab
3
surufatinib
2
pazopanib
2
pasireotide
2
lutetium Lu 177 dotatate
2
amino-acid, glucose, and electrolyte solution
2
X-Rays
2
Temozolomide
2
Sorafenib
2
Phantoms, Imaging
2
Paclitaxel
2
Oxaliplatin
2
Ipilimumab
2
Doxorubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neuroendocrine Tumors
×
Radiosurgery
×
Clear all
No trials found.